Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

February 07, 2024 11:07 (London Time)

Cara Therapeutics

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: CARA
Sentiment: 0.4215
MarketCap: 31,429,918.0
High: 0.6 Low: 0.57

Open: 0.58 Close: 0.58 Change: 0.0

You don't have time to read all about Cara Therapeutics Company Inc. An AI summarizes all the information for you.

This document will help you to evaluate Cara Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cara Therapeutics are: Cara, Therapeutics, Inc, CARA, stock, price, quote, …

Concept Map

...

Semantic Network

...

Stock Summary

Cara Therapeutics, Inc. focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the.

Today's Summary

Cara Therapeutics, Inc. (CARA) stock price, quote, news & analysis. Enter text into the input field will update the search result below. Cara Therapeutics Inc. (NASDAQ:CARA) given consensus recommendation of “moderate buy” by brokerages - defense world.     The prominent players in the cannabinoid derived pharmaceutical industry include: Cara.

Today's News

Cara Therapeutics, Inc. (CARA) stock price, quote, news & analysis. Enter text into the input field will update the search result below. Cara Therapeutics Inc. (NASDAQ:CARA) given consensus recommendation of “moderate buy” by brokerages - defense world.     The prominent players in the cannabinoid derived pharmaceutical industry include: Cara.

Stock Profile

"Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate, including Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. Cara Therapeutics, Inc. has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. and Winhealth Pharma for the co-development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis in China; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. The company was incorporated in 2004 and is based in Stamford, Connecticut."

Keywords

Are looking for the most relevant information about Cara Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Cara Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Cara Therapeutics are: Cara, Therapeutics, Inc, CARA, stock, price, quote, and the most common words in the summary are: therapeutic, cara, premium, job, company, stock, buy, . One of the sentences in the summary was: (CARA) stock price, quote, news & analysis. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #cara #premium #job #company #stock #buy.

Read more →

Related Results

...
February 07, 2024 11:07 (London Time)

Cara Therapeutics

Cara Therapeutics, Inc. (CARA) stock price, quote, news & analysis. Enter text into the input field will update the search result below. Cara Therap…
Sector: Pharmaceuticals
Ticker: CARA
Sentiment: 0.4215
MarketCap: 31,429,918.0
High: 0.6 Low: 0.57

Open: 0.58 Close: 0.58 Change: 0.0

Read more →
...
June 27, 2023 9:02 (London Time)

Cara Therapeutics

Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviat…
Sector: Pharmaceuticals
Ticker: CARA
Sentiment: 0.4588
MarketCap: 174,905,655.0
High: 3.53 Low: 3.21

Open: 3.45 Close: 3.24 Change: -0.21

Read more →
...
July 25, 2023 21:19 (London Time)

Cara Therapeutics

Zacks: Cara Therapeutics - CARA - Stock Price Today - Zacks Is It Time to Buy CARA? Shares are down today. Cara Therapeutics (NASDAQ:CARA) is a favo…
Sector: Pharmaceuticals
Ticker: CARA
Sentiment: 0.9201
MarketCap: 156,011,526.0
High: 2.92 Low: 2.78

Open: 2.88 Close: 2.79 Change: -0.09

Read more →